Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Market Cap	3.33B +2.8%
Revenue (ttm)	1.65B -2.7%
Net Income	178.61M +197.6%
EPS	1.50 +197.9%
Shares Out	119.36M
PE Ratio	18.64
Forward PE	14.98
Dividend	0.35 (1.25%)
Ex-Dividend Date	Jun 10, 2026

Volume	236,952
Open	28.20
Previous Close	28.32
Day's Range	27.88 - 28.32
52-Week Range	21.76 - 33.12
Beta	0.40
Analysts	Hold
Price Target	30.53 (+9.43%)
Earnings Date	Aug 5, 2026

About TADAWUL:2070

Saudi Pharmaceutical Industries and Medical Appliances Corporation develops, manufactures, and markets medicinal and pharmaceutical products in the Kingdom of Saudi Arabia, the Middle East, Egypt, Algeria, and Morocco. The company operates through Pharmaceutical Manufacturing, Trading and Distribution Services, and Healthcare Services segments. The company is involved in the sale, marketing, and distribution of pharmaceutical, veterinary, medical equipment, and cosmetics products; and operates and maintains a secondary care hospital. In additio...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1986
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 2070

Financial Performance

In 2025, TADAWUL:2070's revenue was 1.71 billion, an increase of 1.47% compared to the previous year's 1.68 billion. Earnings were 184.36 million, an increase of 651.43%.

Analyst Summary

According to 3 analysts, the average rating for 2070 stock is "Hold." The 12-month stock price target is SAR 30.53, which is an increase of 9.43% from the latest price.

Price Target

SAR 30.53

(9.43% upside)

Analyst Consensus: Hold